RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer. Issue 4 (10th March 2018)

• Record Type: Journal Article
• Authors: Xiao, Chao; Wang, Yupeng; Zheng, Miao; Chen, Jian; Song, Guohe; Zhou, Zhijie; Zhou, Chongzhi; Sun, Xing; Zhong, Lin; Ding, Erxun; Zhang, Yi; Yang, Liu; Wu, Gang; Xu, Shifeng; Zhang, Hong; Wang, Xiaoliang
• Is Part Of: Cancer science. Volume 109:Issue 4(2018)
• Page Start: 1075
• Page End: 1087
• Publication Date: 2018-03-10
• Subjects: apoptosis -- cell cycle -- preoperative radiotherapy -- RBBP6 -- rectal cancer; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13516
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : Radiotherapy (RT) can be used as preoperative treatment to downstage initially unresectable locally rectal carcinoma, but radioresistance and recurrence remain significant problems. Retinoblastoma binding protein 6 (RBBP6) has been implicated in the regulation of cell cycle, apoptosis and chemoresistance both in vitro and in vivo. The present study investigated whether the inhibition of RBBP6 expression would improve radiosensitivity in human colorectal cancer cells. After SW620 and HT29 cells were exposed to radiation, the levels of RBBP6 mRNA and protein increased over time in both cells. Moreover, a significant reduction in clonogenic survival and a decrease in cell viability in parallel with an obvious increase in cell apoptosis were demonstrated in irradiated RBBP6‐knockdown cells. Transfection with RBBP6 shRNA improved the levels of G2‐M phase arrest, which blocked the cells in a more radiosensitive period of the cell cycle. These observations indicated that cell cycle and apoptosis mechanisms may be connected with tumor cell survival following radiotherapy. In vivo, the tumor growth rate of nude mice in the RBBP6‐knockdown group was significantly slower than that in other groups. These results indicated that RBBP6 overexpression could resist colorectal cancer cells against radiation by regulating cell cycle and apoptosis pathways, and inhibition of RBBP6 could enhance radiosensitivity of human colorectal cancer. Abstract : This study investigated whether the inhibition of RBBP6 expression would improve radiosensitivity in human colorectal cancer. The results showed that RBBP6 might resist colorectal cancer cells against radiation by regulating cell cycle and apoptosis pathways, and inhibition of RBBP6 could enhance radiosensitivity of human colorectal cancer.